Cancer Research
Senescent Non-Cancer Cells Inside Tumors Are Reshaping Cancer Outcomes
A new review reveals how senescent healthy cells within tumors quietly drive cancer progression and therapy resistance.
Review
Jul 2, 2026 0
Results for "Senomorphics"
20 articles
Regenerative Medicine
Lineage Tracing Reaches a New Era With Barcodes, Genetics, and Natural Variants
A landmark review maps the three pillars of modern lineage tracing and how they're reshaping our understanding of cell fate decisions.
Review
Jun 4, 2026 0
Regenerative Medicine
3D Tumor Models Advance Cancer Research Through Bioengineered Tissue Systems
New review explores how 3D organoids and bioengineered niches are revolutionizing tumor research and treatment development.
Review
Apr 8, 2026 0
Supplements
NMN vs NR Supplements Compared: What the Evidence Actually Shows in 2026
A candid breakdown of top NAD+ booster brands reveals strong biomarker data but slim evidence for real longevity outcomes.
Review
May 23, 2026 0
Supplements
Top Longevity Supplement Stacks Ranked by Ingredients and Evidence
Expert reviews compare leading senolytic and NAD+ supplement brands on ingredients, evidence quality, and value.
Review
Apr 23, 2026 0
Cancer Research
Single-Cell Technology Transforms Cancer Treatment and Drug Discovery
New review reveals how advanced genomics tools are revolutionizing cancer diagnosis and therapy development.
Review
Apr 8, 2026 0
Cancer Research
A New Framework for Targeting Cancer's Hidden Ally: Tumor Fibroblasts
Researchers propose a unified model classifying cancer-associated fibroblasts by molecular phenotype and spatial location to guide precision therapy.
Review
Jun 30, 2026 0
Longevity & Aging
Anti-Aging Drug Research Mapped Across 20 Years Using Bibliometric Analysis
A sweeping review organizes 20 years of anti-aging pharmacology into three intervention axes and ranks the top compounds by research impact.
Review
Jun 29, 2026 0
Cancer Research
Sympathetic Neurons May Fuel Cancer Growth Through NPY Signaling
New research reveals how tumors might hijack sympathetic nervous system signals to boost their metabolism and proliferation.
Review
Apr 9, 2026 0
Supplements
NMN vs NR in 2026: Which NAD+ Precursor Actually Wins
Expert reviews compare NMN and NR head-to-head. NMN edges out for muscle and sleep benefits; NR leads for neuroprotection.
Review
May 15, 2026 0
Supplements
NMN vs NR: Which NAD+ Supplement Actually Has the Evidence Behind It
A 2026 comparative review of leading NAD+ supplements reveals NR has stronger human data, while NMN marketing often outpaces clinical proof.
Review
May 21, 2026 0
Gut & Microbiome
AI and Genomics Team Up to Outsmart Antibiotic Resistance
Machine learning and whole-genome sequencing may finally give doctors the tools to predict bacterial resistance before treatment fails.
Review
Jun 29, 2026 0
Supplements
NMN vs NR: 2026 Expert Reviews Rank the Best NAD+ Supplements
New expert reviews compare NMN and NR head-to-head, ranking top products by purity, absorption, and clinical evidence.
Review
Apr 22, 2026 0
Supplements
NMN vs NR: Which NAD+ Booster Actually Delivers Results in 2026
A head-to-head comparison of NMN and NR supplements reveals distinct benefit profiles — and major quality gaps across popular brands.
Review
Apr 20, 2026 0
Regenerative Medicine
From Aging Theories to Epigenetic Reprogramming: A Field in Transformation
A new review traces how aging science evolved from single-cause theories to partial reprogramming with Yamanaka factors as a lifespan-extending strategy.
Review
Jun 30, 2026 0
Cancer Research
How a Common Oral Bacterium Quietly Drives Cancer Growth
Fusobacterium nucleatum has shifted from suspected bystander to confirmed cancer driver — here's what the science reveals.
Review
Jun 3, 2026 0
Cancer Research
EMT Drives Cancer Spread Through a Spectrum of Reversible Cell States
A new review reveals how epithelial-to-mesenchymal transition fuels tumor invasion, immune evasion, and drug resistance through dynamic, reversible states.
Review
Apr 26, 2026 0
Cancer Research
Myeloid Cell Plasticity Emerges as a Key Target for Next-Gen Cancer Therapies
A new review reframes how myeloid cells fuel or fight tumors, pointing to plasticity — not just cell diversity — as the core therapeutic target.
Review
May 14, 2026 0
Supplements
NMN vs NR in 2026: Which NAD Supplement Actually Wins
Expert reviews compare NMN and NR on human trial data, bioavailability, and top-ranked brands for 2026.
Review
May 10, 2026 0
Cancer Research
Personalized Neoantigen Cancer Vaccines Are Moving From Lab to Clinic
A Dana-Farber review maps the path for personalized cancer vaccines — pinpointing which tumors, timing, and combination strategies will matter most.
Review
May 12, 2026 0
Page 1 of 2Next